BB&T Investment Services’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$835K Sell
13,568
-263
-2% -$16.4K 0.14% 148
2017
Q3
$883K Buy
13,831
+4,235
+44% +$247K 0.18% 120
2017
Q2
$533K Sell
9,596
-1,673
-15% -$91K 0.13% 144
2017
Q1
$613K Sell
11,269
-1,393
-11% -$76.4K 0.24% 92
2016
Q4
$741K Buy
+12,662
New +$692K 0.54% 47

Other funds holding BMY

BB&T Investment Services's BMY Position: Q4 2017 in Review

BB&T Investment Services reduced its Bristol-Myers Squibb (BMY) stake by 1.9% in Q4 2017, selling an estimated $16.4K and leaving 13,568 shares worth $835K. The position accounts for 0.14% of the portfolio, ranked #148.

BB&T Investment Services first reported a position in BMY in Q4 2016 and has held it in 5 quarters since. The position peaked at $883K in Q3 2017. 1,735 funds tracked by Wall St. Rank hold BMY as of Q4 2017.

  • BB&T Investment Services held 13,568 shares of Bristol-Myers Squibb worth $835K as of Q4 2017.
  • BB&T Investment Services sold 263 Bristol-Myers Squibb shares in Q4 2017, an estimated $16.4K.
  • Bristol-Myers Squibb made up 0.14% of BB&T Investment Services's portfolio in Q4 2017, its #148 holding.
  • BB&T Investment Services first reported a position in Bristol-Myers Squibb in Q4 2016 and has held it in 5 quarters since.
  • BB&T Investment Services's Bristol-Myers Squibb position peaked at $883K in Q3 2017.
  • 1,735 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2017.

Based on BB&T Investment Services's 13F filing for Q4 2017, filed 15 Feb 2018.